Healios K.K. Stock OTC Markets
Stocks
HLOSF
JP3835100003
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
10:17:30 2026-05-26 EDT
|
5-day change | 1st Jan Change | ||
| 1.800 USD | -.--% |
|
-.--% | -6.74% |
| 07-27 | Healios Announces Selection of Akt-01/Hlcn061 Commercial Manufacturing Process for Amed Project | CI |
| 04-08 | Japan Stocks Rise as US-Iran Ceasefire Eases Geopolitical Concerns | MT |
| Market Cap | 37.14B 236M 208M 197M 178M 334M 22.6B 338M 2.36B 909M 11.54B 884M 865M | P/E 2026 * |
-6.82x | P/E 2027 * | -12x |
|---|---|---|---|---|---|
| Enterprise Value | 36.88B 234M 206M 195M 177M 332M 22.44B 335M 2.34B 903M 11.46B 878M 859M | EV / Sales 2026 * |
73x | EV / Sales 2027 * | 10.3x |
| Free-Float |
79.1% | Yield 2026 * |
-
| Yield 2027 * | - |
| 6 months | -33.33% | ||
| Current year | -6.74% |
| Current year | 1.8 |  | 2.75 |
| 1 year | 1.8 | | 3.63 |
| 3 years | 0.93 | | 4.45 |
| 5 years | 0.93 | | 4.45 |
| 10 years | 0.93 | | 18.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hardy Kagimoto
CEO | Chief Executive Officer | 49 | 2018-02-28 |
Richard Kincaid
DFI | Director of Finance/CFO | 49 | 2019-07-15 |
Yoshie Tsurumaki
CTO | Chief Tech/Sci/R&D Officer | - | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Hardy Kagimoto
BRD | Director/Board Member | 49 | 2012-01-31 |
Richard Kincaid
BRD | Director/Board Member | 49 | 2018-02-28 |
Seigo Kashii
BRD | Director/Board Member | 73 | 2018-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 236M | |
| -0.70% | -4.28% | +52.62% | +86.42% | 71.53B | |
| +0.09% | +1.60% | +37.59% | +81.84% | 60.12B | |
| +4.77% | +6.16% | +36.77% | +26.10% | 27.98B | |
| -1.73% | -4.30% | -18.37% | +357.94% | 25.25B | |
| -0.51% | -2.28% | +0.48% | -9.27% | 24.76B | |
| +0.67% | +1.66% | +20.88% | -4.66% | 20.99B | |
| +3.46% | +3.02% | +158.90% | +337.81% | 15.54B | |
| +0.48% | +0.86% | +44.56% | +168.42% | 14.53B | |
| +2.96% | +0.83% | -5.25% | +519.59% | 14.41B | |
| Average | +0.95% | -0.79% | +36.47% | +173.80% | 30.57B | |
| Weighted average by Cap. | +0.54% | -1.52% | +36.64% | +129.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 505M 3.2M 2.83M 2.68M 2.43M 4.55M 308M 4.59M 32.1M 12.37M 157M 12.03M 11.77M | 3.74B 23.73M 20.94M 19.82M 17.97M 33.69M 2.28B 34.03M 238M 91.62M 1.16B 89.12M 87.18M |
| Net income | -3.63B -23.01M -20.3M -19.21M -17.42M -32.66M -2.21B -32.98M -230M -88.81M -1.13B -86.39M -84.51M | -1.81B -11.46M -10.12M -9.57M -8.68M -16.27M -1.1B -16.43M -115M -44.25M -562M -43.04M -42.1M |
| Net Debt | -260M -1.65M -1.45M -1.38M -1.25M -2.34M -158M -2.36M -16.5M -6.36M -80.73M -6.19M -6.05M | 1.46B 9.28M 8.19M 7.75M 7.03M 13.17M 890M 13.3M 92.94M 35.82M 455M 34.84M 34.08M |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4593 Stock
- HLOSF Stock
Select your edition
All financial news and data tailored to specific country editions
